Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 141 articles: HTML format Text format

Single Articles

January 2012
1. BRUNET S , Labopin M, Esteve J, Cornelissen J, et al
   Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. XU H , Cheng C, Devidas M, Pei D, et al
   ARID5B Genetic Polymorphisms Contribute to Racial Disparities in the Incidence and Treatment Outcome of Childhood Acute Lymphoblastic Leukemia.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. MARCUCCI G , Metzeler KH, Schwind S, Becker H, et al
   Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. FERRARA F
   Prediction of Early Death in Acute Myeloid Leukemia.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
5. GOPALUNI S , Sanyal S, Bair A, Vajpayee N, et al
   Hairy Cell Leukemia Variant in a Patient With Chronic Myeloid Leukemia Receiving Nilotinib: Sequential or Coincidental?
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
6. WALENSKY LD
   From Mitochondrial Biology to Magic Bullet: Navitoclax Disarms BCL-2 in Chronic Lymphocytic Leukemia.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
7. HILLMEN P
   Targeted Therapy for Chronic Lymphocytic Leukemia: A Glimpse Into the Future.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
8. ROBERTS AW , Seymour JF, Brown JR, Wierda WG, et al
   Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. CORTES JE
   Not Only Response but Early Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
10. GOLDIN LR , Kristinsson SY, Liang XS, Derolf AR, et al
    Familial Aggregation of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
11. WARD DE , Fondaw MB, Shroff SK, Reddy VS, et al
    Diffuse Osteosclerosis-Associated Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
12. KEYHANI M
    Use of Arsenic Trioxide As a First-Line Single Agent in the Treatment of Acute Promyelocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
13. MAHMOUDI N
    Research on Acute Promyelocytic Leukemia Conducted in Iran.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
14. WANG X , Spielberger R, Huang Q
    Hairy Cell Leukemia Variant, a New Entity of the WHO 2008.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
15. YI JH , Huh J, Kim HJ, Kim SH, et al
    Adverse Prognostic Impact of Abnormal Lesions Detected by Genome-Wide Single Nucleotide Polymorphism Array-Based Karyotyping Analysis in Acute Myeloid Leukemia With Normal Karyotype.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. TIBES R , Noel P
    Activity of Alemtuzumab in Acute Myelogenous Leukemia and Myelodysplastic Syndrome With Chromosome 7 Aberrations.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
17. MARIN D , Ibrahim AR, Lucas C, Gerrard G, et al
    Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
18. MASUDA S
    DNMT3A Mutations in Acute Myeloid Leukemia: Impact on Low-Risk Patients With CEBPA Mutations.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
19. HODSON A , Crichton S, Montoto S, Mir N, et al
    Use of Zidovudine and Interferon Alfa With Chemotherapy Improves Survival in Both Acute and Lymphoma Subtypes of Adult T-Cell Leukemia/Lymphoma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. TONINO SH , Rijssenbeek AL, Oud ME, Pals ST, et al
    Intracerebral Infiltration As the Unique Cause of the Clinical Presentation of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
21. ROBIER C , Neubauer M, Beham-Schmid C, Sill H, et al
    Thrombotic Microangiopathy and Disseminated Intravascular Coagulation Associated With Carcinocythemia in a Patient With Breast Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
22. PARSONS HM , Harlan LC, Seibel NL, Stevens JL, et al
    Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
    J Clin Oncol. 2011;29:4045-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. PARKER WT , Lawrence RM, Ho M, Irwin DL, et al
    Sensitive Detection of BCR-ABL1 Mutations in Patients With Chronic Myeloid Leukemia After Imatinib Resistance Is Predictive of Outcome During Subsequent Therapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. JABBOUR E , Kantarjian HM, O'Brien S, Shan J, et al
    Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SKILES JL , Imel EA, Christenson JC, Bell JE, et al
    Fluorosis Because of Prolonged Voriconazole Therapy in a Teenager With Acute Myelogenous Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
26. WIERDA WG , O'Brien S, Wang X, Faderl S, et al
    Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. WALTER RB , Othus M, Borthakur G, Ravandi F, et al
    Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. SWERDLOW AJ , Higgins CD, Smith P, Cunningham D, et al
    Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
29. TE WINKEL ML , Pieters R, Hop WC, de Groot-Kruseman HA, et al
    Prospective Study on Incidence, Risk Factors, and Long-Term Outcome of Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. GAN Y , Shinohara MM, Rosenbach M, Elder D, et al
    Transient Blood Transfusion Reaction Masquerading As a Post-Transplantation Lymphoproliferative Disorder Mimicking Acute Leukemia Cutis.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
31. MARIN D , Ibrahim AR, Goldman JM
    European Treatment and Outcome Study (EUTOS) Score for Chronic Myeloid Leukemia Still Requires More Confirmation.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
32. KAMEN BA , Bertino JR, Holcenberg JS, Bleyer WA, et al
    Are we getting closer to using methotrexate in an optimal manner?
    J Clin Oncol. 2011;29:3493-4.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
33. FISCHER K , Cramer P, Busch R, Stilgenbauer S, et al
    Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. PIRO E , Carillio G, Levato L, Kropp M, et al
    Reversal of Leukostasis-Related Pulmonary Distress Syndrome After Leukapheresis and Low-Dose Chemotherapy in Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
35. INABA H , Rubnitz JE, Coustan-Smith E, Li L, et al
    Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. HOF J , Krentz S, van Schewick C, Korner G, et al
    Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. GOVINDAN R , Bogart J, Stinchcombe T, Wang X, et al
    Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non-Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. KANTARJIAN H , O'Brien S, Jabbour E, Shan J, et al
    Impact of Treatment End Point Definitions on Perceived Differences in Long-Term Outcome With Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. CHO SF , Liu YC, Tsai HJ, Lin SF, et al
    Myeloid Sarcoma Mimicking Nasopharyngeal Carcinoma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
40. MEIER DE , Brawley OW
    Palliative care and the quality of life.
    J Clin Oncol. 2011;29:2750-2.
    PubMed     Text format     Related articles   
    
    
    
    
41. O'BRIEN CE , Saratsis AM, Voyadzis JM
    Granulocytic sarcoma in a patient with blast crisis mimicking a chronic subdural hematoma.
    J Clin Oncol. 2011;29:e569-71.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
42. MEKI A , O'Connor D, Roberts C, Murray J, et al
    Hemophagocytic Lymphohistiocytosis in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
43. KRISTINSSON SY , Bjorkholm M, Hultcrantz M, Derolf AR, et al
    Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. HASSELBALCH HC , Kiladjian JJ, Silver RT
    Interferon alfa in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms.
    J Clin Oncol. 2011;29:e564-5.
    PubMed     Text format     Related articles   
    
    
    
    
45. THOL F , Friesen I, Damm F, Yun H, et al
    Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes.
    J Clin Oncol. 2011;29:2499-506.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. MILLOT F , Baruchel A, Guilhot J, Petit A, et al
    Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. THOL F , Damm F, Ludeking A, Winschel C, et al
    Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SCHLICK K , Schilcher G, Krisper P, Neumeister P, et al
    Spontaneous tumor lysis syndrome presenting as acute renal failure in an adult with de novo aleukemic T-ALL: value of renal biopsy?
    J Clin Oncol. 2011;29:e494-6.
    PubMed     Text format     Related articles   
    
    
    
    
49. GHAVAMZADEH A , Alimoghaddam K, Rostami S, Ghaffari SH, et al
    Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. ESTEY EH
    Newly Diagnosed Acute Promyelocytic Leukemia: Arsenic Moves Front and Center.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
51. ROLLIG C , Bornhauser M, Thiede C, Taube F, et al
    Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. TRBUSEK M , Smardova J, Malcikova J, Sebejova L, et al
    Missense Mutations Located in Structural p53 DNA-Binding Motifs Are Associated With Extremely Poor Survival in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. SCHAICH M , Rollig C, Soucek S, Kramer M, et al
    Cytarabine Dose of 36 g/m2 Compared With 12 g/m2 Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SCHANZ J , Steidl C, Fonatsch C, Pfeilstocker M, et al
    Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system.
    J Clin Oncol. 2011;29:1963-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. JADERSTEN M , Saft L, Smith A, Kulasekararaj A, et al
    TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
    J Clin Oncol. 2011;29:1971-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. GARCIA-MANERO G , Gore SD, Cogle C, Ward R, et al
    Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. BJORKHOLM M , Ohm L, Eloranta S, Derolf A, et al
    Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. KRITHARIS A , Brody J, Koduru P, Teichberg S, et al
    Acute Basophilic Leukemia Associated With Loss of Gene ETV6 and Protean Complications.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
59. TOPP MS , Kufer P, Gokbuget N, Goebeler M, et al
    Targeted Therapy With the T-Cell-Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. CHEN Y , Cortes J, Estrov Z, Faderl S, et al
    Persistence of Cytogenetic Abnormalities at Complete Remission After Induction in Patients With Acute Myeloid Leukemia: Prognostic Significance and the Potential Role of Allogeneic Stem-Cell Transplantation.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. KRONKE J , Schlenk RF, Jensen KO, Tschurtz F, et al
    Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. O'FLYNN EA , Wilson R, Nerurkar A, Johnston SR, et al
    Metastatic Breast Cancer in a Young Adult Man After Total-Body Irradiation for Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
63. BJORKHOLM M , Derolf AR, Hultcrantz M, Kristinsson SY, et al
    Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
64. MIKKELSEN TS , Sparreboom A, Cheng C, Zhou Y, et al
    Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.
    J Clin Oncol. 2011;29:1771-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
65. RIMM DL , Nielsen TO, Jewell SD, Rohrer DC, et al
    Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
66. PARK JK , Gelber AC, Zheng G, McDevitt MA, et al
    Large-Vessel Vasculitis As an Early Manifestation of Chronic Myelomonocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
67. SINGHAL V , Kuiper J, Chavda K, Kashmer D, et al
    Spontaneous Splenic Rupture As First Manifestation of Acute Myeloid Leukemia: Case Report and Review of Literature.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
68. LUBBERT M , Suciu S, Baila L, Ruter BH, et al
    Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. GONZALEZ D , Martinez P, Wade R, Hockley S, et al
    Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. NAINA HV , Levitt D, Vusirikala M, Anderson LD Jr, et al
    Successful Treatment of Relapsed and Refractory Extramedullary Acute Promyelocytic Leukemia With Tamibarotene.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
71. SCHLICK K , Regauer S, Beham-Schmid C, Cerroni L, et al
    Pyoderma Gangrenosum Heralding Acute Leukemia for Months: Diagnostic Hint Written on the Skin.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
72. VIGIL CE , Wang SA, Cortes JE, Bueso-Ramos C, et al
    Dasatinib-Responsive Mast Cell Neoplasms As Initial Presentation of Chronic Myelogenous Leukemia in Blast Phase.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
73. ARORA NK , Reeve BB, Hays RD, Clauser SB, et al
    Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective.
    J Clin Oncol. 2011;29:1280-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
74. HEHLMANN R , Lauseker M, Jung-Munkwitz S, Leitner A, et al
    Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-{alpha} in Newly Diagnosed Chronic Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. KANTARJIAN H , Cortes J
    Considerations in the Management of Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
76. APLENC R , Blaney SM, Strauss LC, Balis FM, et al
    Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.
    J Clin Oncol. 2011;29:839-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. HORAN JT , Logan BR, Agovi-Johnson MA, Lazarus HM, et al
    Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
    J Clin Oncol. 2011;29:805-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
78. SZCZEPANSKI T , van der Velden VH, Waanders E, Kuiper RP, et al
    Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. GAIDZIK VI , Bullinger L, Schlenk RF, Zimmermann AS, et al
    RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. METZELER KH , Maharry K, Radmacher MD, Mrozek K, et al
    TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. BARBUI T , Barosi G, Birgegard G, Cervantes F, et al
    Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.
    J Clin Oncol. 2011;29:761-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. WOYACH JA , Ruppert AS, Heerema NA, Peterson BL, et al
    Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. PUI CH , Carroll WL, Meshinchi S, Arceci RJ, et al
    Biology, risk stratification, and therapy of pediatric acute leukemias: an update.
    J Clin Oncol. 2011;29:551-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. KORNBLITH AB , Lan L, Archer L, Partridge A, et al
    Quality of Life of Older Patients With Early-Stage Breast Cancer Receiving Adjuvant Chemotherapy: A Companion Study to Cancer and Leukemia Group B 49907.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. RAVANDI F
    Gemtuzumab ozogamicin: one size does not fit all--the case for personalized therapy.
    J Clin Oncol. 2011;29:349-51.
    PubMed     Text format     Related articles   
    
    
    
    
86. GANGAT N , Caramazza D, Vaidya R, George G, et al
    DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
    J Clin Oncol. 2011;29:392-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
87. FELDMAN EJ , Lancet JE, Kolitz JE, Ritchie EK, et al
    First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. WALTER RB , Gooley TA, Wood BL, Milano F, et al
    Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. CHRISTOULAS D , Matsouka C, Chatzinikolaou I, Barmparoussi D, et al
    Relapse of Ovarian Cancer With Bone Marrow Infiltration and Concurrent Emergence of Therapy-Related Acute Myeloid Leukemia: A Case Report.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
90. MARCUCCI G , Haferlach T, Dohner H
    Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. BURNETT A , Wetzler M, Lowenberg B
    Therapeutic Advances in Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. GRIBBEN JG , O'Brien S
    Update on Therapy of Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. SANZ MA , Lo-Coco F
    Modern Approaches to Treating Acute Promyelocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. KONOPLEVA MY , Jordan CT
    Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. CORTES J , Hochhaus A, Hughes T, Kantarjian H, et al
    Front-Line and Salvage Therapies With Tyrosine Kinase Inhibitors and Other Treatments in Chronic Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. BASSAN R , Hoelzer D
    Modern Therapy of Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. GREVER MR , Lozanski G
    Modern Strategies for Hairy Cell Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. GIARDINO AA , O'Regan K, Jagannathan JP, Elco C, et al
    Richter's Transformation of Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
99. DAMM F , Oberacker T, Thol F, Surdziel E, et al
    Prognostic Importance of Histone Methyltransferase MLL5 Expression in Acute Myeloid Leukemia.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. INABA H , Londero M, Maurer SH, Onciu M, et al
     Acute Megakaryoblastic Leukemia Without GATA1 Mutation After Transient Myeloproliferative Disorder in an Infant Without Down Syndrome.
     J Clin Oncol. 2011.
     PubMed     Text format     Related articles   
     
     
     
     December 2010
101. HO PA , Kuhn J, Gerbing RB, Pollard JA, et al
     WT1 Synonymous SNP rs16754 Correlates With Higher mRNA Expression and Predicts Significantly Improved Outcome in Favorable-Risk Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. CHEN CI , Bergsagel PL, Paul H, Xu W, et al
     Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. BURNETT AK , Hills RK, Milligan D, Kjeldsen L, et al
     Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. PUI CH , Pei D, Campana D, Bowman WP, et al
     Improved Prognosis for Older Adolescents With Acute Lymphoblastic Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. ABRAHAMSSON J , Forestier E, Heldrup J, Jahnukainen K, et al
     Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. ZHANG L , Bennett JM, Zhang X, Moscinski L, et al
     Uncommon of the Uncommon: Low-Grade Myelodysplastic Syndrome Evolving Into Chronic Myelogenous Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
107. DREYER ZE , Dinndorf PA, Camitta B, Sather H, et al
     Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission and MLL Gene Rearrangements: A Report From the Children's Oncology Group.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. CATCHPOOLE DR , Kennedy P, Skillicorn DB, Simoff S, et al
     The curse of dimensionality: a blessing to personalized medicine.
     J Clin Oncol. 2010;28:e723-4.
     PubMed     Text format     Related articles   
     
     
     
     November 2010
109. BLUM W , Klisovic RB, Becker H, Yang X, et al
     Dose escalation of lenalidomide in relapsed or refractory acute leukemias.
     J Clin Oncol. 2010;28:4919-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. SCHWIND S , Maharry K, Radmacher MD, Mrozek K, et al
     Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. LIBBY E , Movva S, Quintana D, Abdul-Jaleel M, et al
     Cytomegalovirus retinitis during chemotherapy with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone.
     J Clin Oncol. 2010;28:e661-2.
     PubMed     Text format     Related articles   
     
     
     
     October 2010
112. SPATARO V
     Nilotinib in a Patient With Postnecrotic Liver Cirrhosis Related to Imatinib.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
113. MORTON LM , Curtis RE, Linet MS, Bluhm EC, et al
     Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma Subtype.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. SILVESTRIS N , Zito FA, Fiore MG, Simone G, et al
     Synchronous Presentation of B-Cell Chronic Lymphocytic Leukemia/Small-Cell Lymphoma and Colon Adenocarcinoma Within the Same Mesenteric Lymph Nodes and a Single Liver Metastasis.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
115. LOU Y , Meng H, Mao L, Jin J, et al
     Bone Marrow Relapse of Medulloblastoma Mimicking Acute Leukemia With Translocation (1;18)(p33;q22).
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
116. CONKLIN HM , Reddick WE, Ashford J, Ogg S, et al
     Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors.
     J Clin Oncol. 2010;28:4465-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. ISHITSUKA K , Fukushima T, Tsukasaki K, Tobinai K, et al
     Is Zidovudine and Interferon-Alfa the Gold Standard for Adult T-Cell Leukemia-Lymphoma?
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
118. STEENSMA DP
     A cello for Michayla.
     J Clin Oncol. 2010;28:4400-1.
     PubMed     Text format     Related articles   
     
     
     
     September 2010
119. ARICO M , Schrappe M, Hunger SP, Carroll WL, et al
     Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. IMAHASHI N , Ohashi H, Arita K, Kitamura K, et al
     Acute Lymphoblastic Leukemia of Male-Recipient Origin Demonstrating Female Karyotype After Cord Blood Transplantation.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
121. KATZ JB , Curran AL, Zemba-Palko V, Dabrow MB, et al
     Synchronous Diagnosis of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
122. SMITH SM , van Besien K, Karrison T, Dancey J, et al
     Temsirolimus Has Activity in Non-Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. PARIKH SA , Bhusal Y, Faderl SH, Wierda WG, et al
     The Great Imitator: Systemic Nocardiosis Mimicking Richter's Transformation in Relapsed Chronic Lymphocytic Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
124. PITINI V , Arrigo C, Altavilla G
     How cells respond to interferons.
     J Clin Oncol. 2010;28:e439.
     PubMed     Text format     Related articles   
     
     
     
     August 2010
125. SCHLENK RF , Dohner K, Mack S, Stoppel M, et al
     Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. FISCHER T , Stone RM, Deangelo DJ, Galinsky I, et al
     Phase IIB Trial of Oral Midostaurin (PKC412), the FMS-Like Tyrosine Kinase 3 Receptor (FLT3) and Multi-Targeted Kinase Inhibitor, in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome With Either Wild-Type or Mutated FLT3.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. LOWENBERG B , Morgan G, Ossenkoppele GJ, Burnett AK, et al
     Phase I/II Clinical Study of Tosedostat, an Inhibitor of Aminopeptidases, in Patients With Acute Myeloid Leukemia and Myelodysplasia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
128. CHRISTIAN B , Zhao W, Hamadani M, Sotomayor EM, et al
     Mantle Cell Lymphoma 12 Years After Allogeneic Bone Marrow Transplantation Occurring Simultaneously in Recipient and Donor.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
129. REDDY N , Thompson-Arildsen MA
     Hodgkin's Lymphoma: Richter's Transformation of Chronic Lymphocytic Leukemia Involving the Liver.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
130. OCHS RC , Gormley RH, Luger S, Bagg A, et al
     Isolated Bowel Relapse in Acute Promyelocytic Leukemia: An Unusual Site of Extramedullary Recurrence.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
131. ZENZ T , Eichhorst B, Busch R, Denzel T, et al
     TP53 Mutation and Survival in Chronic Lymphocytic Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
132. LIN TS , Donohue KA, Byrd JC, Lucas MS, et al
     Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
133. LEE RJ , Came N, Lim A, Harrison SJ, et al
     Lessons Learned From an Unusual Presentation of CD3+, CD56- T-Cell Large Granular Lymphocyte Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     July 2010
134. LUGTHART S , Groschel S, Beverloo HB, Kayser S, et al
     Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. THOMAS DA , O'Brien S, Faderl S, Garcia-Manero G, et al
     Chemoimmunotherapy With a Modified Hyper-CVADand Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome-Negative Precursor B-Lineage Acute Lymphoblastic Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. CHESON BD
     Ofatumumab, a novel anti-CD20 monoclonal antibody for the treatment of B-cell malignancies.
     J Clin Oncol. 2010;28:3525-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. KOHLMANN A , Grossmann V, Klein HU, Schindela S, et al
     Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. HOLLINK IH , van den Heuvel-Eibrink MM, Zimmermann M, Balgobind BV, et al
     No Prognostic Impact of the WT1 Gene Single Nucleotide Polymorphism rs16754 in Pediatric Acute Myeloid Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
139. MATHEWS V , George B, Chendamarai E, Lakshmi KM, et al
     Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. GUTIERREZ A , Dahlberg SE, Neuberg DS, Zhang J, et al
     Absence of Biallelic TCR{gamma} Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
141. EHLERS S , Herbst C, Zimmermann M, Scharn N, et al
     Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.
     J Clin Oncol. 2010;28:2591-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: